Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

Autor: Tropé G., Claes, Dobbs, Stephen, Essapen, Sharadah, Hoskins, P., Green, John, Gilby, E., Van Baal, M., Twigg, Jeremy, Van Der Burg, Maria E.L., Godfrey, Keith, Lacave, Angel J., Angioli, R., Nath, Rahul, Chin, Kirk, Redman, Charles, Lotocki, R., Olaitan, Adeola, Mosgaard, B., Rustin, G., Ind, Thomas, Persic, Mojca, Hogg, Martin, Van Der Velden, J., Ledermann, J., Peter Sykes, Peter Sykes, Madhavan, Krishnawam, Kannisto, P., Hird, Vicky, Evans, A., Sandvei R., R., Gauthier, P., Cruickshank, D.J., Ottevanger, P.B., Pearson, Sheila, Kitchener, Henry, Hall, Marcia, Bessette, P., Pecorelli, S., Gerdin, E., Lopes, Tito, Fish, Andrew, Barlow., Clare, Van Eygen, K., Floquet, A., Tholander, B., Gul, N., Gornall, Robert, Luesley, David, Kirwan, Philip, Symonds, Paul, Henry, Richard, Poole, David, McNeish, Ian, Hocking, Mark, Sammaraie, Al, Speiser, P., Leblanc, E., Green, J.A., De Oliveira, C.F., Grimshaw, R., Zola, P., Parkin, David, Lamb, Martin, Hong, Anne, Gillespie, Alan, Hamid, Abdel, Ahmed, Ahmed, Plante, M., De Valk, B., Nordin, A., Clamp, Andrew, Perez, David, Graham Dark, Graham Dark, Ferguson, Michelle, MacGregor, Carol, Skailes, Geraldine, Jones, Rachel, Cawdell, G., Leeson, Simon, Elit, L., Dittrich, C., Gotlieb, W., Cullimore, John, Crosse, Barbara, Ridley, Paul, Head, Anthony, Nieto, Joaquin, Awwad, Saif, Brinkmann, Dirk, Eustace, Damian, Hindley, Andrew, Katsaros, D., Popadiuk, C., Kristeller, Tome, Redman, C., Chan, S., Marth, C., Yiannakis, Dennis, Lankaster, Kate, Beynon, Gareth, Suhail, Anwar, Indrajit, Fernando, Quigley, Mary, Adeyemi, Olu, Lofts, Fiona, McNally, Orla, Tristam, Amanda, Lee, Martin, Counsell, R., Gleeson, N., Papadopoulos, A., Maggino, T., Honkoop, A., Ghatage, P., Vermorken, J.B., De Greve, J., Boman, K., Petru, E, Amant, F., Vergote, Ignace ^*, Coens, Corneel, Nankivell, Matthew, Kristensen, Gunnar B, Parmar, Mahesh K B, Ehlen, Tom, Jayson, Gordon C, Johnson, Nick, Swart, Ann Marie, Verheijen, René, McCluggage, W Glenn, Perren, Tim, Panici, Pierluigi Benedetti, Kenter, Gemma, Casado, Antonio, Mendiola, Cesar, Stuart, Gavin, Reed, Nick S, Kehoe, Sean

Publikováno v: In The Lancet Oncology December 2018 19(12):1680-1687

2022-VA-1059-ESGO Omental flap as a spacer to reduce acute bowel toxicity after adjuvant radiotherapy

Autor: Elaine Leung, Yash Choudhary, Sofia Parveen, Anthony Packwood, Zahra Pervaiz, Audrey Kwong, Indrajit Fernando, Kavita Singh

Publikováno v: Miscellaneous.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::96d67206d9e9a7f9d9dcd2cc7d968bbf
https://doi.org/10.1136/ijgc-2022-esgo.429

Outcomes Following Interval Debulking Surgery in Primary Peritoneal Carcinoma

Autor: Caroline F, Connolly, Sundus, Yahya, Kiong Kong, Chan, Kavita, Singh, Sudha, Sundar, Suhail M, Anwar, Indrajit, Fernando

Publikováno v: Anticancer research. 36(1)

Primary peritoneal carcinoma (PPC) has a poor prognosis, with a median survival of 11-24 months. Unlike ovarian cancer, there exist no published data on the effectiveness of interval debulking surgery (IDS) in PPC and it is not routine practice. Our

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::df25998e57a3f64435261190b67ea197
https://pubmed.ncbi.nlm.nih.gov/26722051

Chemotherapy for Uterine Carcinosarcoma with Carboplatin, Ifosfamide and Mesna

Autor: Ravi Kumar, Dandamudi, Shazad, Aslam, Nawaz, Walji, Ahmed, El-Modir, Indrajit, Fernando

Publikováno v: Anticancer research. 35(9)

Uterine carcinosarcomas (UCSs) are highly aggressive, rare, biphasic tumors composed of epithelial and mesenchymal elements. Surgery remains the mainstay of treatment in early-stage disease. Adjuvant pelvic radiotherapy improves locoregional control

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bf670a046e3ab405f706a7f6a15608b8
https://pubmed.ncbi.nlm.nih.gov/26254376

Acute Chemotherapy–Related Toxicity Is Not Increased in BRCA1 and BRCA2 Mutation Carriers Treated for Breast Cancer in the United Kingdom

Autor: Douglas F. Easton, Andrew D Baildam, Elizabeth Bancroft, Linda Ashcroft, Andrew Tutt, Kate M. McReynolds, Indrajit Fernando, Rosalind A. Eeles, Audrey Ardern-Jones, Susan Shanley, G.T. Royle, Lori J. Pierce, Sue Ashley, Diana Eccles, Shirley Hodgson, Gerald Gui, Ian E. Smith, Anthony Howell, D. Gareth Evans, Susan C Short, Roger A'Hern, John Yarnold, Lester Barr

Publikováno v: Clinical Cancer Research. 12:7033-7038

Purpose: To evaluate acute toxicity induced by chemotherapy for breast cancer in a retrospective study of 62 BRCA1/2 mutation carriers matched 1:1 with women who had treatment for sporadic disease in the United Kingdom between 1983 and 2003. Experime

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76edab87b6875d3a8c30033a76a8cf96
https://doi.org/10.1158/1078-0432.ccr-06-1246